We develop unique, T cell-recruiting antibody-therapy for patients suffering from solid tumors where current treatment options fail. At TWYCE, our physician scientists develop combinatorial, bispecific antibody therapies from bench to clinical practice. Our capabilities and alliances accelerate product development to enable sustainable business success and to ultimately benefit our patients.